HONA — Honeywell Aerospace Inc

The maiden standalone earnings report in early August 2026 triggered a sharp selloff: FY26 organic sales growth guidance was cut from 7%-9% to 4%-5%, adjusted EBIT was guided flat, and Q2 2026 net income fell roughly 70% YoY due to $329M in transaction costs, $200M in standalone interest, and supply-chain constraints. Sell-side firms have been recalibrating targets — Jefferies went to $175 — so sentiment remains defensive and HONA is firmly in a 'show-me' phase.

Revenue is still growing but decelerating: Q2 2026 grew 5.4% YoY versus Q1 2026's 6.8%. The bigger issue is margin compression: operating margin fell from 23.6% in Q2 2025 to 12.8% in Q2 2026, while gross margin slipped from 36.5% to 35.0%. This is not a one-quarter blip — both 2026 quarters show the squeeze, and management's guidance cut confirms continuation. Demand itself is strong with backlog up 9% YoY to $18.2B, so this looks more like a supply-constrained trough than a structural demand collapse.

As of 2026-08-27, the reported TTM P/E of 67.8x and P/S of 5.74x are misleading because they only reflect the first two post-spin quarters and are depressed by transaction costs and spin-related interest. They look rich versus the 3-year average P/E of 26.7x, but that average comes from a different pre-spin capital structure. On consensus FY27 EPS of $8.10, the forward P/E is roughly 19.8x, which is reasonable if execution recovers. The trailing PEG of 4.16 is not meaningful given the one-off charges distorting current EPS.

At $160.75, the stock is no longer pricing in aggressive growth; it is discounting guidance failure and supply-chain stigma. However, consensus EPS of $8.10 still embeds a meaningful earnings recovery by FY27. If management proves throughput in Q3/Q4, the stock can re-rate toward the $175-$200 area. If supply-chain drag persists, estimates will come down and the ~20x forward multiple offers limited downside cushion.

As of 2026-08-27, RSI was 37.5 — weak but not deeply oversold. Price was 7.15% below its 20-day SMA and 20.84% below its 50-day SMA, reflecting a clear short- and medium-term downtrend following the post-earnings gap. Support sits near the 52-week low of $150.03. A short-term bounce is possible, but the trend remains down until HONA can reclaim its 20-day moving average.

• Persistent aerospace tier-2/tier-3 supplier bottlenecks and skilled-labor shortages are capping output despite record end-demand.
• Higher-for-longer interest rates amplify the burden of HONA's new standalone debt, including roughly $200M in annual interest expense.
• Elevated global defense spending and strong commercial aftermarket demand support the $18.2B backlog.
• Post-spinoff dynamics — index inclusion, shareholder turnover, and limited trading history — are adding volatility and valuation uncertainty.

• September 2026 investor conferences (Jefferies, Vertical Research, Morgan Stanley) where management defends guidance and supply-chain strategy.
• Q3/Q4 2026 operational execution — early evidence that capital deployed into the supply base accelerates deliveries and restores margins.
• Continued conversion of the $18.2B commercial aerospace backlog (+9% YoY).
• Any FY27 guidance reset that reflects supply-chain improvement and aftermarket momentum.

• Supply-chain constraints persist longer than expected, forcing another guidance cut and further margin compression.
• High leverage and negative stockholders' equity of -$5.7B leave limited balance-sheet flexibility.
• Post-spin overhang: passive rebalancing, legacy shareholder selling, or thin trading data could keep volatility elevated.
• OEM production disruptions or defense program delays could slow backlog conversion and revenue growth.

Honeywell Aerospace is a high-quality aerospace franchise with strong demand, a growing backlog, and long-term aftermarket tailwinds, but near-term financials are genuinely impaired by supply-chain limits, spin-off costs, and a heavier standalone balance sheet. As of 2026-08-27, risk/reward is balanced: the stock is no longer priced for perfection, but it needs execution proof before it becomes a compelling buy.

Calculated by applying a 21x forward P/E to consensus FY27 EPS of $8.10 — a discount to the old 26.7x average to reflect the weaker standalone balance sheet and current margin compression, but a premium to today's ~19.8x forward multiple to reflect the strong backlog and aftermarket growth. Cross-check: $170.10 implies roughly 2.9x forward revenue, a reasonable multiple for a mid-single-digit-growth aerospace supplier with 36% gross margins.